 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Bind Therapeutics
BIND
conference date: May 9, 2016 @ 5:30 AM Pacific Time
Sold My BIND on July 5, 2016. no further coverage expected
Bind Therapeutics Makes Deal to Pay Down Loan [May 19, 2016]
Surprise: Bind Therapeutics Seeks Bankruptcy Protection [May 2, 2016]
I'm Accumulating Bind Therapeutics At These Levels [April 8, 2016 @ Seeking Alpha]
2016 |
|||
05/09/2016 |
|||
2015 |
|||
05/07/2015 |
08/06/2015 |
11/02/2015 |
03/15/2016 |
Bind Therapeutics (BIND) is a developer and manufacturer of therapies called accurins.
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMD |
| AMGN |
| BIIB |
| BIND |
| CLDX |
| CELG |
| EPZM |
| GILD |
| GLYC |
| HNSN |
| INO |
| INTC |
| ISRG |
| JUNO |
| MACK |
| MCHP |
| MDVN |
| MYL. |
| NVDA |
| OPXA |
| PLX |
| REGN |
| SGEN |
| XLNX |
| XLRN |
Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. This is investment journalism, not financial advice.
Copyright 2015 William P. Meyers